CSC ServiceWorks Appoints Mark Reinbold as Chief Executive Officer
"Mark is a proven operator and growth leader with deep experience building profitable, service-led business models at scale," said
Reinbold brings more than two decades of leadership experience across global service and infrastructure organizations. Most recently, he served as CEO of Kamran and Company, LLC, leading teams that deliver complex infrastructure solutions supported by strong execution and long-term customer partnerships. Prior to Kamran and Company, Reinbold spent nearly 20 years with Johnson Controls, including leadership roles in sustainable infrastructure. In those roles, he helped shift portions of the business from traditional product-led sales to an Infrastructure-as-a-Service approach—combining technology enablement, performance commitments, and long-term service agreements to deliver measurable customer outcomes over time. He led global teams delivering large-scale service and infrastructure solutions and was a visible executive voice on "as-a-service" models and smart building outcomes.
"I'm honored to join CSC ServiceWorks," said Reinbold. "CSC has a strong foundation, talented teams, and a clear opportunity to increase value through disciplined execution, operational alignment, and a service model that deepens customer relationships. I look forward to partnering with the team to build on that momentum."
"On behalf of the Board, I want to thank
About CSC ServiceWorks
CSC ServiceWorks is a leading provider of laundry solutions and air services, delivering reliable, technology-enabled offerings to multi-family and commercial customers across
View original content to download multimedia:https://www.prnewswire.com/news-releases/csc-serviceworks-appoints-mark-reinbold-as-chief-executive-officer-302714752.html
SOURCE CSC ServiceWorks, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hanon Systems Announces Second Quarter 2026 Financial Results
- RHI Magnesita 2026 Half Year Results: Consistent Self-help Delivery and Strong Steel Business Performance Delivers 42% Adj. EBITA Growth on Constant Currency Basis
- IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share